Schweiger, V.; Villagrossi, L.; Taus, F.; Gottin, L.; Bonora, E.; Anderloni, M.; Varrassi, G.; Polati, L.; Nizzero, M.; Martini, A.;
et al. Acetyl-L-Carnitine as an Add-On Treatment in Fibromyalgia Syndrome: A Retrospective Analysis on 183 Patients, According to the Generalized Linear Mixed Model for Longitudinal Data. Biomedicines 2025, 13, 820.
https://doi.org/10.3390/biomedicines13040820
AMA Style
Schweiger V, Villagrossi L, Taus F, Gottin L, Bonora E, Anderloni M, Varrassi G, Polati L, Nizzero M, Martini A,
et al. Acetyl-L-Carnitine as an Add-On Treatment in Fibromyalgia Syndrome: A Retrospective Analysis on 183 Patients, According to the Generalized Linear Mixed Model for Longitudinal Data. Biomedicines. 2025; 13(4):820.
https://doi.org/10.3390/biomedicines13040820
Chicago/Turabian Style
Schweiger, Vittorio, Libera Villagrossi, Francesco Taus, Leonardo Gottin, Eleonora Bonora, Marco Anderloni, Giustino Varrassi, Luca Polati, Marta Nizzero, Alvise Martini,
and et al. 2025. "Acetyl-L-Carnitine as an Add-On Treatment in Fibromyalgia Syndrome: A Retrospective Analysis on 183 Patients, According to the Generalized Linear Mixed Model for Longitudinal Data" Biomedicines 13, no. 4: 820.
https://doi.org/10.3390/biomedicines13040820
APA Style
Schweiger, V., Villagrossi, L., Taus, F., Gottin, L., Bonora, E., Anderloni, M., Varrassi, G., Polati, L., Nizzero, M., Martini, A., & Polati, E.
(2025). Acetyl-L-Carnitine as an Add-On Treatment in Fibromyalgia Syndrome: A Retrospective Analysis on 183 Patients, According to the Generalized Linear Mixed Model for Longitudinal Data. Biomedicines, 13(4), 820.
https://doi.org/10.3390/biomedicines13040820
